INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6001, 1883, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6002, 3088, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6003, 4215, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6004, 4663, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6005, 4813, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6006, 4814, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6007, 4859, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6008, 5394, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6009, 5862, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6010, 6287, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6011, 6288, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6012, 6694, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6013, 6826, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6014, 6933, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6015, 8209, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6016, 10139, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6017, 11112, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6018, 11403, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6019, 14060, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6020, 14204, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6021, 15171, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6022, 15173, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6023, 17014, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6024, 17974, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6025, 18649, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6026, 18982, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6027, 18996, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6028, 19254, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6029, 20005, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6030, 20006, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6031, 20168, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6032, 20170, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6033, 20173, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6034, 20175, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6035, 20176, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6036, 20606, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6037, 20895, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6038, 20970, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6039, 21834, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6040, 25047, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6041, 27837, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6042, 28533, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6043, 33550, 'Iron', 'Concomitant use of some food may reduce the bioavailability of orally administered iron, and vice versa.', 'food', 'Moderate', 'Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect.  Some studies suggest administration of iron with ascorbic acid may enhance bioavailability.  In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased.  Consult the product labeling for specific separation times and monitor clinical responses as appropriate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6044, 0, 'Isocarboxazid', 'Foods that contain large amounts of tyramine may precipitate a hypertensive crisis in patients treated with monoamine oxidase inhibitors (MAOIs).  The mechanism is inhibition of MAO-A, the enzyme responsible for metabolizing exogenous amines such as tyramine in the gut and preventing them from being absorbed intact.  Once absorbed, tyramine is metabolized to octopamine, a substance that is believed to displace norepinephrine from storage granules.', 'Tyrosine-rich foods', 'Major', 'In general, patients treated with MAOIs or other agents that possess MAOI activity (e.g., furazolidone, linezolid, procarbazine) should avoid consumption of products that contain large amounts of amines and protein foods in which aging or breakdown of protein is used to increase flavor.  These foods include cheese (particularly strong, aged or processed cheeses), sour cream, wine (particularly red wine), champagne, beer, pickled herring, anchovies, caviar, shrimp paste, liver (particularly chicken liver), dry sausage, salamis, figs, raisins, bananas, avocados, chocolate, soy sauce, bean curd, sauerkraut, yogurt, papaya products, meat tenderizers, fava bean pods, protein extracts, yeast extracts, and dietary supplements.  Caffeine may also precipitate hypertensive crisis so its intake should be minimized as well.  At least 14 days should elapse following discontinuation of MAOI therapy before these foods may be consumed.  Specially designed reference materials and dietary consultation are recommended so that an appropriate and safe diet can be planned.  Patients should be advised to promptly seek medical attention if they experience potential signs and symptoms of a hypertensive crisis such as severe headache, visual disturbances, difficulty thinking, stupor or coma, seizures, chest pain, unexplained nausea or vomiting, and stroke-like symptoms.  Patients should also be counseled not to use MAOIs with alcohol, and to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6045, 6615, 'Isoniazid', 'Alcoholic patients have been shown to have a higher incidence of isoniazid-induced hepatotoxicity.  The mechanism has not been established.', 'alcohol', 'Moderate', 'Patients should be counseled to avoid the combination of alcohol and isoniazid and clinicians should be aware of the risk for increased hepatotoxicity in these patients.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6046, 11126, 'Isoniazid', 'Alcoholic patients have been shown to have a higher incidence of isoniazid-induced hepatotoxicity.  The mechanism has not been established.', 'alcohol', 'Moderate', 'Patients should be counseled to avoid the combination of alcohol and isoniazid and clinicians should be aware of the risk for increased hepatotoxicity in these patients.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6047, 11127, 'Isoniazid', 'Alcoholic patients have been shown to have a higher incidence of isoniazid-induced hepatotoxicity.  The mechanism has not been established.', 'alcohol', 'Moderate', 'Patients should be counseled to avoid the combination of alcohol and isoniazid and clinicians should be aware of the risk for increased hepatotoxicity in these patients.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6048, 20987, 'Isoniazid', 'Alcoholic patients have been shown to have a higher incidence of isoniazid-induced hepatotoxicity.  The mechanism has not been established.', 'alcohol', 'Moderate', 'Patients should be counseled to avoid the combination of alcohol and isoniazid and clinicians should be aware of the risk for increased hepatotoxicity in these patients.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6049, 20988, 'Isoniazid', 'Alcoholic patients have been shown to have a higher incidence of isoniazid-induced hepatotoxicity.  The mechanism has not been established.', 'alcohol', 'Moderate', 'Patients should be counseled to avoid the combination of alcohol and isoniazid and clinicians should be aware of the risk for increased hepatotoxicity in these patients.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6050, 27840, 'Isoniazid', 'Alcoholic patients have been shown to have a higher incidence of isoniazid-induced hepatotoxicity.  The mechanism has not been established.', 'alcohol', 'Moderate', 'Patients should be counseled to avoid the combination of alcohol and isoniazid and clinicians should be aware of the risk for increased hepatotoxicity in these patients.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6051, 27843, 'Isoniazid', 'Alcoholic patients have been shown to have a higher incidence of isoniazid-induced hepatotoxicity.  The mechanism has not been established.', 'alcohol', 'Moderate', 'Patients should be counseled to avoid the combination of alcohol and isoniazid and clinicians should be aware of the risk for increased hepatotoxicity in these patients.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6052, 6615, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'food', 'Moderate', 'Isoniazid should be administered on an empty stomach, one hour before or two hours after meals.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6053, 11126, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'food', 'Moderate', 'Isoniazid should be administered on an empty stomach, one hour before or two hours after meals.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6054, 11127, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'food', 'Moderate', 'Isoniazid should be administered on an empty stomach, one hour before or two hours after meals.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6055, 20987, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'food', 'Moderate', 'Isoniazid should be administered on an empty stomach, one hour before or two hours after meals.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6056, 20988, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'food', 'Moderate', 'Isoniazid should be administered on an empty stomach, one hour before or two hours after meals.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6057, 27840, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'food', 'Moderate', 'Isoniazid should be administered on an empty stomach, one hour before or two hours after meals.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6058, 27843, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'food', 'Moderate', 'Isoniazid should be administered on an empty stomach, one hour before or two hours after meals.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6059, 6615, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'Tyrosine-rich foods', 'Moderate', 'Patients should be advised to avoid foods containing tyramine (e.g., aged cheese, cured meats such as sausages and salami, fava beans, sauerkraut, soy sauce, beer, or red wine) or histamine (e.g., skipjack, tuna, mackerel, salmon) during treatment with isoniazid.  Corticosteroids and antihistamines may be considered if histamine intoxication is suspected.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6060, 11126, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'Tyrosine-rich foods', 'Moderate', 'Patients should be advised to avoid foods containing tyramine (e.g., aged cheese, cured meats such as sausages and salami, fava beans, sauerkraut, soy sauce, beer, or red wine) or histamine (e.g., skipjack, tuna, mackerel, salmon) during treatment with isoniazid.  Corticosteroids and antihistamines may be considered if histamine intoxication is suspected.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6061, 11127, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'Tyrosine-rich foods', 'Moderate', 'Patients should be advised to avoid foods containing tyramine (e.g., aged cheese, cured meats such as sausages and salami, fava beans, sauerkraut, soy sauce, beer, or red wine) or histamine (e.g., skipjack, tuna, mackerel, salmon) during treatment with isoniazid.  Corticosteroids and antihistamines may be considered if histamine intoxication is suspected.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6062, 20987, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'Tyrosine-rich foods', 'Moderate', 'Patients should be advised to avoid foods containing tyramine (e.g., aged cheese, cured meats such as sausages and salami, fava beans, sauerkraut, soy sauce, beer, or red wine) or histamine (e.g., skipjack, tuna, mackerel, salmon) during treatment with isoniazid.  Corticosteroids and antihistamines may be considered if histamine intoxication is suspected.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6063, 20988, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'Tyrosine-rich foods', 'Moderate', 'Patients should be advised to avoid foods containing tyramine (e.g., aged cheese, cured meats such as sausages and salami, fava beans, sauerkraut, soy sauce, beer, or red wine) or histamine (e.g., skipjack, tuna, mackerel, salmon) during treatment with isoniazid.  Corticosteroids and antihistamines may be considered if histamine intoxication is suspected.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6064, 27840, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'Tyrosine-rich foods', 'Moderate', 'Patients should be advised to avoid foods containing tyramine (e.g., aged cheese, cured meats such as sausages and salami, fava beans, sauerkraut, soy sauce, beer, or red wine) or histamine (e.g., skipjack, tuna, mackerel, salmon) during treatment with isoniazid.  Corticosteroids and antihistamines may be considered if histamine intoxication is suspected.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6065, 27843, 'Isoniazid', 'Administration with food significantly reduces isoniazid absorption, increasing the risk of therapeutic failure or resistance.', 'Tyrosine-rich foods', 'Moderate', 'Patients should be advised to avoid foods containing tyramine (e.g., aged cheese, cured meats such as sausages and salami, fava beans, sauerkraut, soy sauce, beer, or red wine) or histamine (e.g., skipjack, tuna, mackerel, salmon) during treatment with isoniazid.  Corticosteroids and antihistamines may be considered if histamine intoxication is suspected.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6066, 4128, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6067, 4146, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6068, 4155, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6069, 4164, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6070, 5666, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6071, 6652, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6072, 6655, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6073, 7200, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6074, 13403, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6075, 20986, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6076, 21045, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6077, 23441, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6078, 23442, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6079, 23443, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6080, 26225, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6081, 26226, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6082, 26227, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6083, 26228, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6084, 26229, 'Isotretinoin', 'The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction.', 'alcohol', 'Moderate', 'Alcohol consumption should be avoided during isotretinoin therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6085, 4017, 'Isosorbide mononitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6086, 4018, 'Isosorbide mononitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6087, 4019, 'Isosorbide mononitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6088, 4020, 'Isosorbide mononitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6089, 4021, 'Isosorbide mononitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6090, 0, 'Isradipine', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6091, 0, 'Isradipine', 'The consumption of grapefruit juice may be associated with significantly increased plasma concentrations of some calcium channel blockers (CCBs) when they are administered orally.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', 'The manufacturers of nifedipine and nisoldipine recommend avoiding grapefruit juice.  Patients treated orally with other calcium channel blockers should be advised to avoid consumption of large amounts of grapefruits and grapefruit juice to prevent any undue fluctuations in serum drug levels.  Increased effects on blood pressure may persist for up to 4 days after the consumption of grapefruit juice.  Monitoring for calcium channel blocker adverse effects (e.g., headache, hypotension, syncope, tachycardia, edema) is recommended.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6092, 0, 'Ivacaftor', 'Grapefruit juice may increase the plasma concentrations of ivacaftor.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Elexacaftor and tezacaftor are also CYP450 3A4 substrates in vitro and may interact similarly with grapefruit juice, whereas lumacaftor is not expected to interact.', 'grapefruit juice', 'Moderate', 'Patients treated with ivacaftor-containing medications should avoid consumption of grapefruit juice and any food that contains grapefruit or Seville oranges.  All ivacaftor-containing medications should be administered with fat-containing foods such as eggs, avocados, nuts, meat, butter, peanut butter, cheese pizza, and whole-milk dairy products.  A typical cystic fibrosis diet will satisfy this requirement.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6093, 1691, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6094, 2421, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6095, 3701, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6096, 8563, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6097, 8564, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6098, 14165, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6099, 14166, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6100, 15457, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6101, 25293, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6102, 25294, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6103, 26561, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6104, 26562, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6105, 30085, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6106, 30086, 'Ivabradine', 'Grapefruit juice may significantly increase the plasma concentrations of ivabradine.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ivabradine should avoid or limit consumption of grapefruit or grapefruit juice.  The manufacturer recommends taking ivabradine with meals to reduce variability in exposure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6107, 959, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6108, 6667, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6109, 6669, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6110, 6670, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6111, 6674, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6112, 6675, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6113, 6676, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6114, 6678, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6115, 10830, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6116, 14419, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6117, 19475, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6118, 19476, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6119, 21063, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6120, 21065, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6121, 21067, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6122, 21070, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6123, 27421, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6124, 28046, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'grapefruit juice', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6125, 959, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6126, 6667, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6127, 6669, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6128, 6670, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6129, 6674, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6130, 6675, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6131, 6676, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6132, 6678, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6133, 10830, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6134, 14419, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6135, 19475, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6136, 19476, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6137, 21063, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6138, 21065, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6139, 21067, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6140, 21070, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6141, 27421, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6142, 28046, 'Itraconazole', 'Food increases the absorption of itraconazole capsules but decreases the absorption of itraconazole oral solution.  Cola beverages may increase the bioavailability of itraconazole capsules.  Itraconazole capsules require an acidic gastric pH for adequate dissolution and subsequent absorption.  Cola beverages help lower gastric pH and improve absorption.', 'cola', 'Moderate', 'The manufacturer recommends that the capsules be taken immediately after a full meal and the solution be taken on an empty stomach to ensure maximal absorption.  Cola beverages may help increase the bioavailability of itraconazole capsules, particularly in patients with hypochlorhydria or those treated concomitantly with gastric acid suppressants.  Until more information is available, it may be advisable to avoid the consumption of grapefruits and grapefruit juice during itraconazole therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6143, 0, 'Istradefylline', 'Smoking tobacco may decrease the steady-state systemic exposure of istradefylline by 38% to 54%.', 'cigarette', 'Moderate', 'The possibility of reduced therapeutic effects of istradefylline should be considered in smokers.  The manufacturer recommends an istradefylline dosage of 40 mg once daily in patients who smoke 20 or more cigarettes (or the equivalent amount of another tobacco product) per day.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6144, 2053, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6145, 3639, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6146, 3707, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6147, 3708, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6148, 3709, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6149, 3984, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6150, 6608, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6151, 14162, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6152, 15837, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6153, 15838, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6154, 16808, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6155, 21002, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6156, 21007, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6157, 21008, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6158, 21031, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6159, 30354, 'Isosorbide dinitrate', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6160, 6686, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6161, 6688, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6162, 21086, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6163, 21087, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6164, 21088, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6165, 21089, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6166, 21091, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6167, 21092, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6168, 30720, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (6169, 30721, 'Ivermectin', 'Alcohol may increase the plasma concentrations of ivermectin.  The mechanism of interaction is unknown.', 'alcohol', 'Moderate', 'Patients receiving ivermectin therapy should preferably avoid the consumption of alcohol to prevent any undue adverse effects of ivermectin.', '', '', 'DDInter', 0);